1: Niino S, Nakamura Y, Hirabayashi Y, Nagano-Ito M, Ichikawa S. A small molecule inhibitor of Bcl-2, HA14-1, also inhibits ceramide glucosyltransferase. Biochem Biophys Res Commun. 2013 Apr 5;433(2):170-4. doi: 10.1016/j.bbrc.2013.02.052. Epub 2013 Feb 26. PubMed PMID: 23485465.
2: Thota VN, Brahmaiah M, Kulkarni SS. Synthesis of a C-glycoside analogue of β-galactosyl ceramide, a potential HIV-1 entry inhibitor. J Org Chem. 2013 Dec 6;78(23):12082-9. doi: 10.1021/jo402115w. Epub 2013 Nov 15. PubMed PMID: 24199837.
3: Saied EM, Banhart S, Bürkle SE, Heuer D, Arenz C. A series of ceramide analogs modified at the 1-position with potent activity against the intracellular growth of Chlamydia trachomatis. Future Med Chem. 2015;7(15):1971-80. doi: 10.4155/fmc.15.126. Epub 2015 Oct 23. PubMed PMID: 26496536.
4: Liu J, Beckman BS, Foroozesh M. A review of ceramide analogs as potential anticancer agents. Future Med Chem. 2013 Aug;5(12):1405-21. doi: 10.4155/fmc.13.107. Review. PubMed PMID: 23919551; PubMed Central PMCID: PMC4216473.
5: Ballereau S, Levade T, Genisson Y, Andrieu-Abadie N. Alteration of ceramide 1-O-functionalization as a promising approach for cancer therapy. Anticancer Agents Med Chem. 2012 May;12(4):316-28. Review. PubMed PMID: 21554198.
6: Luttgeharm KD, Cahoon EB, Markham JE. A mass spectrometry-based method for the assay of ceramide synthase substrate specificity. Anal Biochem. 2015 Jun 1;478:96-101. doi: 10.1016/j.ab.2015.02.016. Epub 2015 Feb 26. PubMed PMID: 25725359.
7: Shirey CM, Ward KE, Stahelin RV. Investigation of the biophysical properties of a fluorescently modified ceramide-1-phosphate. Chem Phys Lipids. 2016 Oct;200:32-41. doi: 10.1016/j.chemphyslip.2016.06.004. Epub 2016 Jun 16. PubMed PMID: 27318040; PubMed Central PMCID: PMC5159338.
8: Tidhar R, Sims K, Rosenfeld-Gur E, Shaw W, Futerman AH. A rapid ceramide synthase activity using NBD-sphinganine and solid phase extraction. J Lipid Res. 2015 Jan;56(1):193-9. doi: 10.1194/jlr.D052001. Epub 2014 Nov 3. PubMed PMID: 25368106; PubMed Central PMCID: PMC4274067.
9: Garcia V, Le Faouder P, Dupuy A, Levade T, Ballereau S, Génisson Y. A novel jaspine B-ceramide hybrid modulates sphingolipid metabolism. Chem Biodivers. 2015 Jul;12(7):1115-25. doi: 10.1002/cbdv.201400357. PubMed PMID: 26172331.
10: Tokudome Y, Endo M, Hashimoto F. Application of glucosylceramide-based liposomes increased the ceramide content in a three-dimensional cultured skin epidermis. Skin Pharmacol Physiol. 2014;27(1):18-24. doi: 10.1159/000351350. Epub 2013 Jul 24. PubMed PMID: 23887587.
11: Spinedi A. Brefeldin A limits N-hexanoylsphingosine-induced accumulation of natural ceramide via the salvage pathway by enhancing glucosylation. Lipids. 2014 Feb;49(2):207-10. doi: 10.1007/s11745-013-3858-3. Epub 2013 Nov 6. PubMed PMID: 24194457.
12: Hussain H, Nyongha AT, Dongo E, Ahmed I, Zhang W. Melicilamide A: a new ceramide from Milicia excelsa. Nat Prod Res. 2013;27(14):1246-9. doi: 10.1080/14786419.2012.724416. Epub 2012 Sep 11. PubMed PMID: 22963402.
13: Mielke MM, Maetzler W, Haughey NJ, Bandaru VV, Savica R, Deuschle C, Gasser T, Hauser AK, Gräber-Sultan S, Schleicher E, Berg D, Liepelt-Scarfone I. Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study. PLoS One. 2013 Sep 18;8(9):e73094. doi: 10.1371/journal.pone.0073094. eCollection 2013. PubMed PMID: 24058461; PubMed Central PMCID: PMC3776817.
14: Couttas TA, Lim XY, Don AS. A three-step assay for ceramide synthase activity using a fluorescent substrate and HPLC. Lipids. 2015 Jan;50(1):101-9. doi: 10.1007/s11745-014-3969-5. Epub 2014 Nov 18. PubMed PMID: 25403920.
15: Korbelik M, Zhang W, Separovic D. Monitoring ceramide and sphingosine-1-phosphate levels in cancer cells and macrophages from tumours treated by photodynamic therapy. Photochem Photobiol Sci. 2012 May;11(5):779-84. doi: 10.1039/c2pp05384e. Epub 2012 Feb 22. PubMed PMID: 22354109.
16: Stock RP, Brewer J, Wagner K, Ramos-Cerrillo B, Duelund L, Jernshøj KD, Olsen LF, Bagatolli LA. Sphingomyelinase D activity in model membranes: structural effects of in situ generation of ceramide-1-phosphate. PLoS One. 2012;7(4):e36003. doi: 10.1371/journal.pone.0036003. Epub 2012 Apr 25. PubMed PMID: 22558302; PubMed Central PMCID: PMC3338491.
17: Kota V, Hama H. 2'-Hydroxy ceramide in membrane homeostasis and cell signaling. Adv Biol Regul. 2014 Jan;54:223-30. doi: 10.1016/j.jbior.2013.09.012. Epub 2013 Oct 8. Review. PubMed PMID: 24139861; PubMed Central PMCID: PMC3946364.
18: Li F, Zhang N. Ceramide: Therapeutic Potential in Combination Therapy for Cancer Treatment. Curr Drug Metab. 2015;17(1):37-51. Review. PubMed PMID: 26526831.
19: Stiban J, Perera M. Very long chain ceramides interfere with C16-ceramide-induced channel formation: A plausible mechanism for regulating the initiation of intrinsic apoptosis. Biochim Biophys Acta. 2015 Feb;1848(2):561-7. doi: 10.1016/j.bbamem.2014.11.018. Epub 2014 Nov 21. PubMed PMID: 25462172.
20: Bergman BC, Brozinick JT, Strauss A, Bacon S, Kerege A, Bui HH, Sanders P, Siddall P, Kuo MS, Perreault L. Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans. Am J Physiol Endocrinol Metab. 2015 Aug 15;309(4):E398-408. doi: 10.1152/ajpendo.00134.2015. Epub 2015 Jun 30. PubMed PMID: 26126684; PubMed Central PMCID: PMC4537923.